Physician profile
Christopher Bennett Stalling
NPI 1255695029
$4,954.73
in general payments reported to CMS, 2019-2025
16 companies · $772 in 2025
The $772 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.66 · 2021: $531 · 2022: $1,715 · 2023: $581 · 2024: $1,287 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,848 · Travel and Lodging: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,848.06 |
| Travel and Lodging | $791.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,383.06 | 2019-2025 | Real Intelligence, Journey II, Legion Revision |
| Rock Medical Orthopedics, INC. | $1,225.63 | 2022 | |
| Stryker Corporation | $277.74 | 2021-2024 | Aequalis Perform Reversed, Gamma, Blueprint Patient Specific Instrumentation |
| Zimmer Biomet Holdings, INC. | $258.78 | 2022-2025 | Rosa, Arcos, Oss Orthopedic Salvage System |
| Ebi, LLC | $243.49 | 2025 | Ebi Osteogen Implantable Bone Growth Stimulator, Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Davol INC. | $160.67 | 2025 | Surgiphor |
| Vertex Pharmaceuticals Incorporated | $92.05 | 2025 | |
| Onkos Surgical, INC. | $68.84 | 2025 | Eleos Limb Salvage System |
| Ethicon US, LLC | $52.21 | 2019-2025 | Ethicon |
| Globus Medical, INC. | $44.59 | 2022 | |
| Vericel Corporation | $34.73 | 2021-2024 | Maci |
| Kci USA, INC. | $33.57 | 2019-2023 | V.A.C. Veraflo, Prevena |
| Exactech, INC. | $32.40 | 2024 | |
| Ferring Pharmaceuticals INC. | $16.83 | 2025 | Euflexxa |
| Cumberland Pharmaceuticals, INC. | $16.70 | 2025 | Caldolor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Stalling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.